Breaking News

Mochida Pharmaceutical (4534)

Tokyo

Add to/Remove from Watchlist Add to Watchlist

3,205.0 +15.0 +0.47%

02:00:29 - Closed. Currency in JPY ( Disclaimer )

Type: Equity

Market: Japan

ISIN: JP3922800002

Volume: 20,500
Bid/Ask: 3,200.0 / 3,215.0
Day's Range: 3,170.0 - 3,215.0

General
Chart
- Streaming Chart
- Interactive Chart
Financials
Technical
Forum

Mochida Pharmaceutical Company Profile

Get an in-depth profile of Mochida Pharmaceutical, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

1529

Equity Type

ORD

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology. It offers Lialda for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Lexapro, an antidepressant drug; Epadel drug for hyperlipidemia and arteriosclerosis obliterans; Urece for the treatment of gout and hyperuricemia; and Treprost for the treatment of pulmonary arterial hypertension. In addition, the company provides Atelec to treat calcium channel blocker with a long-acting hypotensive effect; Tramcet, an analgesic for chronic pain and pain after tooth extraction; Heparin Sodium MOCHIDA, an anticoagulant agent; Beselna, a therapeutic agent for condyloma acuminatum and actinic keratosis; and Dinagest, a therapeutic agent for endometriosis, adenomyosis, and dysmenorrhea. Further it offers skin care, baby care, personal care, and nursing products. Additionally, the company develops mesalazine, ethyl icosapentate, daridorexant, dotinurad, and treprostinil drugs for the treatment of ulcerative colitis, hypertriglyceridemia, insomnia, gout and hyperuricemia, and pulmonary hypertension associated with interstitial lung disease; and dMD-001, a medical device that is used for the treatment of articular cartilage lesions, as well as dMD-002, which is used for the treatment of cavernous nerve injury. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

Contact Information

Address 7, Yotsuya 1-chome Shinjuku-ku
Tokyo, 160-8515
Japan

Phone 81 3 3358 7211

Fax 81 3 3358 7887

Web www.mochida.co.jp

Top Executives

Name	Age	Since	Title
Masayoshi Takeda	-	2022	GM, Head of Finance & Accounting Department and Full-Time Audit & Supervisory Board Member
Naoyuki Mochida	-	1999	President & Representative Director
Kyosuke Wagai	-	2016	Outside Audit & Supervisory Board Member
Keiichi Sagisaka	-	2010	Senior Executive Managing Officer of Pharmaceutical Business & Healthcare and Director
Tomoo Kugisawa	-	2012	Independent Outside Director
Kiyoshi Mizuguchi	-	2015	Exec Managing Officer of Research & Development, Supervisor of Pharmaceutical Plant and Director
Yutaka Kawakami	-	2019	Executive Managing Officer, Executive Officer, Head of RA, QA & PV and Executive Director
Junichi Sakaki	-	2014	Senior Exec Managing Officer of Business Development, Supervisor of Biomaterials Business & Director
Yoshiharu Hashimoto	-	2019	Full-Time Audit & Supervisory Board Member
Yoshifumi Miyata	-	2021	Outside Audit & Supervisory Board Member
Nana Otsuki	-	2021	Independent Outside Director
Shigeaki Yoshikawa	-	2023	Independent Outside Director
Akiko Suzuki	-	2019	Outside Audit & Supervisory Board Member
Tomoaki Sonoda	-	2022	Independent Outside Director
Motoi Mitsuishi	-	2023	Member of the Board & Executive Managing Officer
Chu Sakata	-	2011	Senior EVP & Representative Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

4534 Comments

Write your thoughts about Mochida Pharmaceutical

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	38,913.4	+61.1	+0.16%
US 500	5,189.6	+8.9	+0.17%
Dow Jones	38,852.27	+176.59	+0.46%
S&P 500	5,180.74	+52.95	+1.03%
Nasdaq	16,349.25	+192.92	+1.19%
S&P 500 VIX	13.46	-0.03	-0.22%
Dollar Index	104.965	+0.046	+0.04%

Crude Oil WTI	77.72	-0.76	-0.97%
Brent Oil	82.55	-0.78	-0.94%
Natural Gas	2.170	-0.025	-1.14%
Gold	2,328.25	-2.95	-0.13%
Silver	27.613	-0.001	0.00%
Copper	4.5913	-0.0237	-0.51%
US Soybeans	1,241.75	-7.25	-0.58%

U.S. 10Y	4.439	-0.048	-1.07%
U.S. 30Y	4.595	-0.047	-1.00%
U.S. 5Y	4.459	-0.024	-0.54%
U.S. 3M	5.407	+0.019	+0.36%
US 10Y T-Note	109.09	+0.20	+0.19%
Euro Bund	131.75	+0.32	+0.24%
10-2 Yield Spread	-31.02	-1.64	5.58%

Apple	181.71	-1.67	-0.91%
Alphabet A	168.10	+0.86	+0.51%
Tesla	184.76	+3.57	+1.97%
Amazon.com	188.70	+2.49	+1.34%
Netflix	596.97	+17.63	+3.04%
Meta Platforms	465.68	+13.72	+3.04%
Bank of America	37.69	+0.44	+1.18%

Recent Quotes

	Name	Price	Chg.	Chg. %
	4534	3,205.0	+15.0	+0.47%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	184.76	+1.97%	83.40M
AAPL	181.71	-0.91%	74.61M
AMD	155.78	+3.44%	43.89M
NVDA	921.40	+3.77%	36.63M
AMZN	188.70	+1.34%	31.80M
META	465.68	+3.04%	13.96M
BRKa	608,780	+0.96%	17.96K

Name	Last	Chg. %	Vol.
SMCI	830.35	+6.09%	5.19M
AAL	14.65	+5.78%	46.62M
PWR	269.44	+5.11%	1.36M
LUV	27.41	+4.82%	9.59M
MU	120.13	+4.73%	22.01M
UAL	53.97	+4.49%	8.64M
APTV	84.40	+4.43%	4.47M

Name	Last	Chg. %	Vol.
TSN	58.50	-5.68%	10.71M
AMGN	299.48	-3.79%	4.03M
WBA	17.26	-3.09%	11.08M
CHRW	78.75	-3.02%	2.04M
ODFL	180.18	-2.64%	2.05M
FAST	66.74	-2.47%	5.34M
MRNA	122.13	-2.30%	3.94M